Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[DDL 12-08 18] T. Gallem, M. Tservistas, M. Uhlig, S. Seidler, R. Waldner, S. Seemann, M. Keller, M. Knoch: Advancements in ease of dosing for nebulised drug products: Development of a closed, ampoule-based electronic nebulizer system. DDL 19 (Drug Delivery to the Lungs), Edinburgh, UK, December 10-12, 2008.
[DDL 12-08 17] R. Egle, E. Bitterle, F. Gruger, M. Keller: Physicochemical characteristics of a loposomal cyclosporin. A formulation pre and post nebulisation in a customized eFlow® electronic nebulizer. DDL 19 (Drug Delivery to the Lungs), Edinburgh, UK, December 10-12, 2008.
[DDL 12-08 16] E. Bitterle, O. Denk, A. Luithlen, K. Reul, K. Hoyer, M. Uhlig, M. Tservistas, M. Keller: Comparison of aerosol drug delivery efficiency nebulising Colistin by electronic and jet nebulizers. DDL 19 (Drug Delivery to the Lungs), Edinburgh, UK, December 10-12, 2008.
[DDL 12-08 15] E. Bitterle, A. Luithlen, K. Reul, A. Bucholski, M. Tservistas, M. Keller: Recommendation to use a climate box for optimization of cascade impaction measurements ensuring exact control of humidity and impactor temperature. DDL 19 (Drug Delivery to the Lungs), Edinburgh, UK, December 10-12, 2008.
[poster AAPS 2008 CsA 200-1113] Characterization of a liposomal Ciclosporin A (L-CsA) formulation before and after lyophilization and nebulization Roman Egle, Ellen Bitterle, Friedrich Gruber, Manfred Keller
[ECFC 06-08 07] U. Schuschnig, E. Klopfer, A. Krüner, R. Schmid, M. Keller Colistin CF for aerosol therapy of the upper airways. An in-vitro deposition study with the PARI SINUS 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008
[ECFC 06-08 06] E. Bitterle, A. Luithlen, K. Reul, D. Mueller, M. Keller Aerosol Characteristics of Hypertonic Saline (HS) nebulised by the eFlow® rapid 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008
[ECFC 06-08 05] M. Tservistas, K. Hoyer, S. Seemann, M. Keller, M. Knoch Aerosol Characteristics of eFlow® using different control units 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008